yttrium radioisotopes has been researched along with Carcinoma, Medullary in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angerstein, C; Becker, W; Béhé, M; Behr, TM; Gotthardt, M | 1 |
| Bartolomei, M; Bodei, L; Chinol, M; Cremonesi, M; Grana, C; Handkiewicz-Junak, D; Lopera Sierra, M; Mäcke, HR; Mazzetta, C; Paganelli, G; Rocca, P | 1 |
| An, R; Biersack, HJ; Gao, ZR; Zhang, YX | 1 |
| Goldenberg, DM; Juweid, M; Stein, R; Zhang, CH | 1 |
| Goldenberg, DM; Juweid, M; Mattes, MJ; Stein, R | 1 |
| Chen, S; Goldenberg, DM; Reed, L; Richel, H; Stein, R | 1 |
| Cybulla, M; Otte, A; Weiner, SM | 1 |
2 trial(s) available for yttrium radioisotopes and Carcinoma, Medullary
| Article | Year |
|---|---|
Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
Topics: Animals; Carcinoma, Medullary; Cell Line, Tumor; Chelating Agents; Drug Evaluation, Preclinical; Drug Stability; Female; Gastrins; Humans; Indium Radioisotopes; Kinetics; Male; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Staining and Labeling; Thyroid Neoplasms; Tissue Distribution; Whole-Body Counting; Yttrium Radioisotopes | 2003 |
[Targeted radionuclide therapy for patients with metastatic medullary thyroid carcinoma].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Carcinoma, Medullary; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Male; Middle Aged; Octreotide; Pentetic Acid; Positron-Emission Tomography; Remission Induction; Thyroid Gland; Thyroid Hormones; Thyroid Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2006 |
5 other study(ies) available for yttrium radioisotopes and Carcinoma, Medullary
| Article | Year |
|---|---|
Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Humans; Male; Middle Aged; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Somatostatin; Thyroid Neoplasms; Yttrium Radioisotopes | 2004 |
Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Medullary; Combined Modality Therapy; Doxorubicin; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Radioimmunotherapy; Thyroid Neoplasms; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Yttrium Radioisotopes | 1999 |
Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Carcinoembryonic Antigen; Carcinoma, Medullary; Drug Screening Assays, Antitumor; Female; Fluorescent Antibody Technique, Indirect; Half-Life; Humans; Iodine Radioisotopes; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Radiometry; Radiotherapy Dosage; Thyroid Neoplasms; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 1999 |
Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Medullary; Combined Modality Therapy; Dacarbazine; Female; Mice; Mice, Nude; Radioimmunotherapy; Radiopharmaceuticals; Thyroid Neoplasms; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2002 |
Is (90)Y-DOTATOC treatment for neuroendocrine tumours safe?
Topics: Animals; Antineoplastic Agents, Hormonal; Carcinoma, Medullary; Humans; Hypertension, Renal; Kidney Failure, Chronic; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Yttrium Radioisotopes | 2002 |